Skip to main content Deutsch

Philipp Staber

Assoc.Prof. Priv.-Doz. Dr. Philipp B. Staber

Associate Professor
Senior Physician at the Department of Hematology and Hemostaseology
Program director and head of the clinical study groups: Lymphoma, CLL
Head of the laboratory: Functional Precision Hematology

T: +43 (0)1 40400-73782 (Office)
T: +43 (0)1 40400-73795 (Assistance and laboratory)
T: +43 (0)1 40400-44765 (Study team)

Philipp B. Staber is Associate Professor, Head of the Lymphoproliferative Diseases Program and Senior Physician at the Department of Haematology and Haemostaseology at the Medical University of Vienna. After obtaining his doctorate, Dr. Philipp Staber worked as a junior doctor in internal medicine at the Medical University of Graz. He completed his doctorate in Graz and at Harvard Medical School, Boston, MA, USA. From 2009 to 2013, he practiced a postdoctoral research fellowship at the Harvard Stem Cell Institute and the Beth Israel Deaconess Medical Center of Harvard Medical School. He completed his fellowship in hematology and oncology at the Medical University of Graz and the Medical University of Vienna.

In the last 7 years at the Medical University of Vienna, Dr. Philipp Staber built up his own research laboratory with currently 14 members, published several papers in renowned journals and raised more than 6 million euros in research funding. The group established a comprehensive, clinically annotated biobank for hematologic malignancies (viable biobank, "Vivi-bank"), which includes more than 15,000 viable primary patient samples of leukemias and lymphomas, as well as a platform for single-cell drug screening.

Through interdisciplinary collaboration, the generation of structured clinical, functional and high-dimensional data sets in combination with deep machine learning, the group aims to improve the molecular understanding of patients' individual hematologic malignancies and their precise therapeutic targeting. With his clinical research group, he develops and conducts patient-oriented "next generation clinical trials" to evaluate individualized therapeutic strategies and precision medicine approaches in patients with hematologic malignancies. 


  • 2014 Specialized training Haematology and Oncology (board certification)
  • 2014 Certificate: ICH Good Clinical Practice for Clinical Trial
  • 2014 PhD (Dr. med.sci), Dept. Pathology, Medical University Graz, Austria
  • 2010 Venia Docendi for Internal Medicine, Medical University Graz, Austria
  • 2007 Internal Medicine, Certification of Austrian and European Board
  • 1994-2000 MD, Medical University Graz, Austria


  • 2019 – Chair tumour board “Precision Hematology” at Medical University Vienna
  • 2016 – Co-chair tumour board “Lymphoma” at Medical University Vienna
  • 2016 – Director of Lymphoma and CLL program at Medical University Vienna
  • 2015 – Associate Professor of Medicine, Medical University Vienna
  • 2014 – Director of T-cell lymphoma program at Medical University Vienna
  • 2014 – Senior physician, Assistant Professor, Medical University Vienna
  • 2009-2013 Postdoctoral research fellow, Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute, Harvard Medical School (DG Tenen); USA
  • 2007-2008 Fellowship in Hematology and Oncology, Medical University Graz
  • 2001-2007 Residence in Internal Medicine, Medical University Graz

Scholarships and awards

  • 2018 Celgene 2018 Future Leaders Award for Clinical Research Hematology
  • 2012 Marie Curie International Outgoing Fellowship, European Union
  • 2011 APART-fellowship of Austrian Academy of Sciences
  • 2009 Erwin Schrödinger Fellowship, FWF Austrian Science Fund
  • 2006 Award of the Hans und Blanca Moser foundation
  • 2006 + 2009 + 2011 Abstract Achievement Award, American Society of Hematology
  • 2006 Theodor Koerner Award
  • 2005 Main Research Award of the Styrian Cancer Aid foundation
  • 2005 Award of the Sanofi-Aventis Foundation, Austria
  • 2004 Karl Fellinger-Award of the Austrian Cancer Aid Foundation
  • 2002 – 2005 + 2007 Young Investigator’s Award, Austrian Society of Hematology/Oncology
  • 2000 Dissertation award of the Styrian government
  • 2000 Excellence stipend, Dept. of Philosophy, Karl-Franzens University Graz

Selected memberships and functions

  • 2020-2022 Executive Board member of EHA Scientific Working Group: Precision Hematology
  • 2019 – Founder and co-chair of Functional Precision Medicine in Blood Cancer
  • 2017 – Founder and chair of T-PLL International Study group (TPLL-ISG)
  • 2017 – Steering committee member of the German CLL Study Group
  • 2012 – American Society of Hematology (ASH)
  • 2012 – European Hematology Association (EHA)
  • 2010-2013 President Chapter Greater Boston of Austrian Scientists in North America (ASciNA)

Selected lectureships

  • 2015-2018 Organizing institutional lecture series on blood diseases, “Blutiger Donnerstag”
  • 2014-2017 “Leukemia and lymphoma”, lecture and seminar, Medical University Vienna
  • 2007-2008 “Internal Medicine”, hands-on-seminar, Medical University Graz (MUG)
  • 2007-2008 “Microscope diagnostics in hematologic disorders”, MUG
  • 2007-2008 “Internal Medicine – Hematology: Lymphoma”, main lecture, MUG
  • 2006-2008 “Genetics in disease dynamics”, seminar and lecture, MUG
  • 2003-2008 “Molecular biology in Medicine”, seminar, MUG

Pubmed List of publications